Etiologic spectrum and functional outcome of the acute inflammatory myelitis

Edgar Carnero Contentti1, Javier Pablo Hryb2, Ana Diego2

  • 1Department of Neurology, Hospital Carlos G. Durand, University of Buenos Aires, Av Díaz Vélez 5044, Buenos Aires, Argentina. junior.carnero@hotmail.com.

Acta Neurologica Belgica
|January 12, 2017
PubMed

Insights

Longitudinally extensive transverse myelitis (LETM) on MRI indicates a poorer functional outcome for acute inflammatory myelitis (AIM) patients. Early identification of LETM is crucial for predicting long-term disability and guiding treatment strategies.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Radiology

Background:

  • Acute inflammatory myelitis (AIM) diagnosis is challenging due to non-specific clinical, neuroimaging, and laboratory findings.
  • Longitudinally extensive transverse myelitis (LETM) on MRI is linked to poorer functional prognosis in AIM patients.

Purpose of the Study:

  • To evaluate functional outcomes in first-time AIM events, comparing patients with and without LETM on MRI.
  • To identify differential diagnoses associated with specific lesion patterns.

Main Methods:

  • Retrospective analysis of clinical, radiological, and biochemical data.
  • Assessment of functional outcomes using the Winner-Hughes Functional Disability Scale (WHFDS) at 3 and 6 months post-event.
  • Correlation of MRI findings (LETM, lesion location) with clinical presentation and functional prognosis.

Main Results:

  • LETM was associated with significantly worse functional outcomes, including increased wheelchair dependence (OR=7.61 at 3 months, OR=4.8 at 6 months) and need for mobility aids (OR=11.0 at 3 months, OR=4.3 at 6 months).
  • Centromedullary lesions correlated with LETM, while lateral lesions were associated with partial transverse myelitis (PL).
  • Brain MRI lesions indicated conditions like multiple sclerosis and acute disseminated encephalomyelitis.

Conclusions:

  • Acute inflammatory myelitis (AIM) is an etiologically diverse condition.
  • Longitudinally extensive transverse myelitis (LETM) predicts a worse functional prognosis compared to partial lesions (PL) in AIM patients at 3 and 6 months.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
395
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
522
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
282